Huisman M G, Kok M, de Bock G H, van Leeuwen B L
University of Groningen, University Medical Centre Groningen, Department of Surgery, Groningen, 9700 RB, The Netherlands.
University of Groningen, University Medical Centre Groningen, Department of Internal Medicine, Groningen, 9700 RB, The Netherlands; University of Groningen, University Medical Centre Groningen, Department of Medical Oncology, Groningen, 9700 RB, The Netherlands.
Eur J Surg Oncol. 2017 Jan;43(1):1-14. doi: 10.1016/j.ejso.2016.06.003. Epub 2016 Jun 21.
The onco-geriatric population is increasing and thus more and more elderly will require surgery; an important treatment modality for many cancer types. This population's heterogeneity demands preoperative risk stratification, which has led to the introduction of Geriatric Assessment (GA) and associated screening tools in surgical oncology. Many reviews have investigated the use of GA in onco-geriatric patients. Discrepancies in outcomes between studies currently hamper the implementation of a preoperative GA in clinical practice. A systematic review of systematic reviews was performed in order to investigate assessment tools of the most commonly included GA domains and their predictive ability regarding the adverse postoperative outcomes. All domains - except polypharmacy - were, to a varying degree, associated with different adverse postoperative outcomes. Functional status, comorbidity and frailty were assessed most frequently and were most often significant. The association between domain impairments and adverse postoperative outcomes appeared to be greatly influenced by the study population characteristics and selection bias, as well as the type of assessment tool used due to possible ceiling effects and its sensitivity to detect domain impairments. Frailty seems to be the most important predictor, which underpins the importance of an integrated approach. As it is unlikely that one universal GA will fit all, feasibility, based on the time, expertise, and resources available in daily clinical practice as well as the patient population to hand, should be taken into consideration, when tailoring the 'optimal GA'.
老年肿瘤患者群体正在增加,因此越来越多的老年人需要接受手术,这是许多癌症类型的重要治疗方式。该群体的异质性要求进行术前风险分层,这导致了老年评估(GA)及相关筛查工具在外科肿瘤学中的引入。许多综述研究了GA在老年肿瘤患者中的应用。目前,研究结果的差异阻碍了术前GA在临床实践中的实施。为了研究最常纳入的GA领域的评估工具及其对术后不良结局的预测能力,我们进行了一项系统评价的系统综述。除多重用药外,所有领域在不同程度上都与不同的术后不良结局相关。功能状态、合并症和衰弱的评估最为频繁,且往往具有显著性。领域损害与术后不良结局之间的关联似乎受到研究人群特征和选择偏倚的极大影响,以及由于可能的天花板效应及其检测领域损害的敏感性而使用的评估工具类型的影响。衰弱似乎是最重要的预测因素,这突出了综合方法的重要性。由于不可能有一种通用的GA适用于所有人,在定制“最佳GA”时,应考虑基于日常临床实践中可用的时间、专业知识和资源以及手头患者群体的可行性。